|
Volumn 21, Issue 5, 2014, Pages 333-340
|
Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: Interim analysis after 24 weeks of treatment
|
Author keywords
hepatitis C; rash; real life; side effects; telaprevir
|
Indexed keywords
CORTICOSTEROID;
ERYTHROPOIETIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
HEMOGLOBIN;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
TELAPREVIR;
VIRUS RNA;
ANTIVIRUS AGENT;
INTERFERON;
OLIGOPEPTIDE;
ADULT;
AGED;
ANAL COMPLAINT;
ANEMIA;
ANOREXIA;
ANTIVIRAL ACTIVITY;
ANTIVIRAL THERAPY;
ARTHRALGIA;
ARTICLE;
BONE PAIN;
CHILL;
COHORT ANALYSIS;
COUGHING;
DECOMPENSATED LIVER CIRRHOSIS;
DEPRESSION;
DIARRHEA;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FEVER;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
DYSGEUSIA;
DYSPNEA;
FATIGUE;
FEMALE;
FLU LIKE SYNDROME;
FOLLOW UP;
GENOTYPE;
GINGIVITIS;
GLOMERULUS FILTRATION RATE;
HAIR LOSS;
HEPATITIS C;
HEPATITIS C VIRUS GENOTYPE 1;
HUMAN;
INJECTION SITE REACTION;
LEUKOCYTE COUNT;
LEUKOPENIA;
LIMB PAIN;
LIVER CIRRHOSIS;
LOW BACK PAIN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD REVIEW;
MOUTH PAIN;
MYALGIA;
NAUSEA;
NERVOUSNESS;
NEUROPATHY;
OUTCOME ASSESSMENT;
PARESTHESIA;
PRIORITY JOURNAL;
PRURITUS;
RASH;
RELAPSE;
RETROSPECTIVE STUDY;
SIDE EFFECT;
TACHYCARDIA;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT RESPONSE;
VERTIGO;
VIRUS LOAD;
VOMITING;
WEAKNESS;
CLASSIFICATION;
DRUG COMBINATION;
DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;
GENETICS;
HEPACIVIRUS;
ISOLATION AND PURIFICATION;
MIDDLE AGED;
TREATMENT OUTCOME;
YOUNG ADULT;
ADULT;
AGED;
ANTIVIRAL AGENTS;
COHORT STUDIES;
DRUG THERAPY, COMBINATION;
DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;
FEMALE;
GENOTYPE;
HEPACIVIRUS;
HUMANS;
INTERFERONS;
MALE;
MIDDLE AGED;
OLIGOPEPTIDES;
RETROSPECTIVE STUDIES;
RIBAVIRIN;
TREATMENT OUTCOME;
VIRAL LOAD;
YOUNG ADULT;
|
EID: 84898462388
PISSN: 13520504
EISSN: 13652893
Source Type: Journal
DOI: 10.1111/jvh.12145 Document Type: Article |
Times cited : (13)
|
References (15)
|